National Lung Cancer Registry in Men and Women Based on Diagnosis in Algeria

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

897 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-07-19

Study Completion Date

2021-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

National, prospective, multicentric, non-interventional registry-based study, conducted among oncologists, pulmonologists in community and university hospitals, from the public sector in Algeria.

The study will collect information on the characteristics, and lung carcinomas patterns of patients whose lung cancer diagnosis was confirmed by a pathologist during the study period.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

ALG-LungCancerRegistry (SAFRO2202)

NCT07161882

Lung Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Small Cell +1 more

RECRUITING

Italian Lung Cancer Observational Study

NCT05851755

Lung Cancer

ENROLLING_BY_INVITATION

Tunisian Lung Cancer Study

NCT06934499

Pulmonary Cancer

RECRUITING

Ambispective Registry of Patients Affected by Lung Cancer

NCT07274163

Lung Cancer

RECRUITING

A Single-arm Observational Study to Characterize the Demographic, Clinical Features and Outcomes of a Brazilian Cohort of Patients With Lung Cancer.

NCT07279948

Lung Cancer

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study consists of:

* All patients meeting inclusion/exclusion criteria presenting to their oncologists/pulmonologists for a routine visit during recruitment period will be sequentially asked to participate to the study.
* The patients who do not consent will only be reported as new case of lung cancer for the incidence study.

The patients who consent to participate to the study will perform four in-hospital visits (Inclusion visit, visit at 3, 6 and 12 months). In addition to the 4 visits, a phone contact with the patients every 6 months at years 2,3, 4 and 5 will be done by the investigator or one of his/her authorised representative or the CRO or during a routine visit to the investigator, to check the patient's survival status.

THE STUDY DURATION 72 MONTHS

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oncology & Epidemiology & Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lungcancer patients

Men or women diagnosed with lung cancer all types and stages confirmed over 12 months of recruitment period by a pathologist

NIS observational stud

Intervention Type OTHER

NIS observational study : Epidemiologic registry

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NIS observational stud

NIS observational study : Epidemiologic registry

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men or women diagnosed with lung cancer all types and stages confirmed over 12 months of recruitment period by a pathologist

* Aged at least18 years at diagnosis
* Patients who provide their informed consent form